These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19940369)

  • 1. Carperitide and adiponectin--how are they connected each other to benefit acute decompensated heart failure?
    Asanuma H; Kitakaze M
    Circ J; 2009 Dec; 73(12):2206-7. PubMed ID: 19940369
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure patients with diabetes mellitus.
    Yamaji M; Tsutamoto T; Tanaka T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ J; 2009 Dec; 73(12):2264-9. PubMed ID: 19797823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute heart failure due to mitral regurgitation responding dramatically to carperitide (hANP): a case report.
    Tamiya E; Sone M; Koizumi A; Inoue K; Ebihara I; Koide H; Kato Y; Suzuki J; Daida H
    Int J Cardiol; 2008 Mar; 125(1):e6-7. PubMed ID: 17379332
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of carperitide for the treatment of refractory heart failure due to severe acute myocardial infarction.
    Kikuchi M; Nakamura M; Suzuki T; Sato M; Takino T; Hiramori K
    Jpn Heart J; 2001 May; 42(3):271-80. PubMed ID: 11605765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study.
    Nishikimi T; Karasawa T; Inaba C; Ishimura K; Tadokoro K; Koshikawa S; Yoshihara F; Nagaya N; Sakio H; Kangawa K; Matsuoka H
    Circ J; 2009 May; 73(5):892-8. PubMed ID: 19346663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aldosterone and endothelin-1 by carperitide was attenuated with more than 1 week of infusion in patients with congestive heart failure.
    Ishikawa C; Tsutamoto T; Wada A; Fujii M; Ohno K; Sakai H; Yamamoto T; Horie M
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):513-8. PubMed ID: 16160606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atrial natriuretic peptide on adiponectin in patients with heart failure.
    Tanaka T; Tsutamoto T; Sakai H; Nishiyama K; Fujii M; Yamamoto T; Horie M
    Eur J Heart Fail; 2008 Apr; 10(4):360-6. PubMed ID: 18353720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF).
    Nagai T; Honda Y; Nakano H; Honda S; Iwakami N; Mizuno A; Komiyama N; Yamane T; Furukawa Y; Miyagi T; Nishihara S; Tanaka N; Adachi T; Hamasaki T; Asaumi Y; Tahara Y; Aiba T; Sugano Y; Kanzaki H; Noguchi T; Kusano K; Yasuda S; Ogawa H; Anzai T
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):551-557. PubMed ID: 29098501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute efficacy of combined therapy of carperitide and nicorandil for acute decompensated heart failure with left ventricular systolic dysfunction.
    Kajimoto K; Shimamura K
    Int J Cardiol; 2011 Jun; 149(2):e55-e58. PubMed ID: 19395093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy.
    Suwa M; Seino Y; Nomachi Y; Matsuki S; Funahashi K
    Circ J; 2005 Mar; 69(3):283-90. PubMed ID: 15731532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systolic blood pressure at admission as a predictor of the response to initial carperitide therapy in patients hospitalized for acute decompensated heart failure with left ventricular systolic dysfunction.
    Kajimoto K; Sashida Y; Minami Y; Yumino D; Kawarai H; Kasanuki H
    Cardiovasc Drugs Ther; 2009 Dec; 23(6):481-8. PubMed ID: 19937464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.
    Mills RM; LeJemtel TH; Horton DP; Liang C; Lang R; Silver MA; Lui C; Chatterjee K
    J Am Coll Cardiol; 1999 Jul; 34(1):155-62. PubMed ID: 10400005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natriuretic peptides in heart failure.
    Nicholls MG
    J Intern Med; 1994 Jun; 235(6):515-26. PubMed ID: 8207359
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure.
    Oya H; Nagaya N; Furuichi S; Nishikimi T; Ueno K; Nakanishi N; Yamagishi M; Kangawa K; Miyatake K
    Am J Cardiol; 2000 Jul; 86(1):94-8. PubMed ID: 10867102
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
    Okuhara Y; Hirotani S; Ando T; Nishimura K; Orihara Y; Komamura K; Naito Y; Mano T; Masuyama T
    Heart Vessels; 2017 Apr; 32(4):419-427. PubMed ID: 27469321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study.
    Hata N; Seino Y; Tsutamoto T; Hiramitsu S; Kaneko N; Yoshikawa T; Yokoyama H; Tanaka K; Mizuno K; Nejima J; Kinoshita M
    Circ J; 2008 Nov; 72(11):1787-93. PubMed ID: 18812677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.
    Mourouzis I; Giagourta I; Galanopoulos G; Mantzouratou P; Kostakou E; Kokkinos AD; Tentolouris N; Pantos C
    Metabolism; 2013 Oct; 62(10):1387-93. PubMed ID: 23773982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutic options in congestive heart failure: Part I.
    McMurray J; Pfeffer MA
    Circulation; 2002 Apr; 105(17):2099-106. PubMed ID: 11980691
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter prospective investigation on efficacy and safety of carperitide as a first-line drug for acute heart failure syndrome with preserved blood pressure: COMPASS: Carperitide Effects Observed Through Monitoring Dyspnea in Acute Decompensated Heart Failure Study.
    Nomura F; Kurobe N; Mori Y; Hikita A; Kawai M; Suwa M; Okutani Y
    Circ J; 2008 Nov; 72(11):1777-86. PubMed ID: 18832779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BNP-guided therapy for heart failure.
    Piña IL; O'Connor C
    JAMA; 2009 Jan; 301(4):432-4. PubMed ID: 19176447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.